The IVD quality control products market is driven by factors such as increasing number of accredited laboratories, stringent mandates on the use of third party IVD quality control products, and increase in the number of IVD test volumes across the globe. Increase in adoption of multianalyte controls and focus of key players on expanding their market presence in emerging economies are anticipated to create new growth opportunities for market players. However, poor reimbursement scenario and lack of regulations regarding the use of controls in emerging economies are expected to hamper the market growth during the analysis period.
According to the report published by Allied Market Research, In Vitro Diagnostics (IVD) Quality Control Product Market by Product Type (Quality Controls (Whole Blood-based Controls, Serum/Plasma-based Controls, Urine-based Controls, Other IVD Quality Controls), Data Management Software, and Quality Assurance Services), by Application (Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Coagulation/Hemostasis, Microbiology, and Others), by End User (Hospitals, Clinical Laboratories, Research & Academic Institutes, and Others), by Manufacturer Type [Instrument Manufacturer Controls and Independent Manufacturer Controls (Third-party Controls and Instrument Manufacturer Controls)] – Global Opportunity Analysis and Industry Forecast, 2022-2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Request Free Sample Report Now:
Onkar Sumant, a Manager, Healthcare at Allied Market Research, stated, “The growth of the global IVD quality control products market is propelled by increase in adoption of multianalyte third party quality controls,She further added, serum/plasma-based controls products are popular due to their high stability and long self life.”
North America was the highest revenue contributor to the global market. Asia-Pacific is projected to be the fastest-growing region by 2022, registering a CAGR of 4.9% during the forecast period, due to increase in acceptance of third party IVD control products and spiraling number of accredited laboratories in the region.
The key players in the IVD quality control products market have focused on expanding their business operations in the emerging economies by adopting strategies such as new product launches and geographical expansion. The major market players profiled in the report include Abbott Diagnostics, Bio-Rad Laboratories, Inc., Roche Diagnostics, Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Helena Laboratories, Seracare Life Sciences, Inc., Technopath Clinical Diagnostics, and Sun Diagnostics, LLC.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: 1-800-792-5285 |UK: +44-845-528-1300 | Hong Kong: +852-301-84916 | India (Pune): +91-20-66346060 | Fax: +1-855-550-5975 Email” email@example.com
Follow us on LinkedIn, Facebook, Twitter, Pinterest, YouTube & Instagram